Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01641913 · ClinicalTrials.gov registry record · Phase 1
Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01641913: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01641913 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01641913, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Do patient's with eosinophilic esophagitis have increased small intestinal permeability and if this changes in response to topically administered esophageal steroids?
Interventions
- OTHER Absorbable sugars
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01641913
The ClinicalTrials.gov registry entry for NCT01641913 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Absorbable sugars is the first listed.
NCT01641913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01641913 about?
NCT01641913 is a clinical study titled "Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients". Do patient's with eosinophilic esophagitis have increased small intestinal permeability and if this changes in response to topically administered esophageal steroids?
What is the current status of trial NCT01641913?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2012-08. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01641913?
The interventions under investigation include: Absorbable sugars (OTHER).
Who is sponsoring clinical trial NCT01641913?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.